Anton Kopitzsch, Lead Automation Engineering, Glatt Process & Plant Engineering, and Pascal Neumann, Expert Pharma Technology Systems Digitalization, Bayer, will devote their session to revolutionizing the manufacture of solid oral dosage forms, outlining fully automated batch execution in an automated production environment.

The joint project between Glatt and Bayer represents a pioneering step towards the digital transformation and automation of pharmaceutical manufacturing. At its core is a collaborative development process that integrates process, engineering, automation, and IT expertise to create a digitalized and automated production environment for oral solid dosage forms. From the outset, the project was driven by a shared vision of end-to-end digital execution — from planning and design to implementation and operation. This approach enabled the seamless integration of process equipment, data systems, and monitoring control mechanisms into a unified, intelligent manufacturing ecosystem. The result is a scalable, modular solution that supports flexible production campaigns, real-time monitoring, and automated documentation. By combining digital project management with deep pharmaceutical know-how, Glatt and Bayer have set a new benchmark for efficiency, compliance, and innovation in the industry.